+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Coronavirus Test Kits Market in North America 2023-2027

  • PDF Icon

    Report

  • 147 Pages
  • October 2023
  • Region: North America
  • TechNavio
  • ID: 5027178
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The test kits market in North America is forecasted to grow by USD -8.77 bn during 2022-2027, accelerating at a CAGR of -23.81% during the forecast period. The report on the test kits market in North America provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising adoption of rapid coronavirus test kits, fastrack approval of coronavirus diagnostic kits, and government initiatives to boost sales of coronavirus test kits.

The test kits market in North America is segmented as below:

By End-user

  • Government
  • Non-government

By Type

  • Rapid test kit
  • RT-PCR
  • Others
This study identifies the launch of new covid-19 test kits as one of the prime reasons driving the test kits market in North America growth during the next few years. Also, emergence of new covid-19 variants and advancements in technology to develop rapid and accurate test kits will lead to sizable demand in the market.

The report on the test kits market in North America covers the following areas:

  • Test kits market in North America sizing
  • Test kits market in North America forecast
  • Test kits market in North America industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading test kits market in North America vendors that include Abbott Laboratories, Advaite Inc., Becton Dickinson and Co., Biomedomics Inc., bioMerieux SA, Cellex Inc., Co Diagnostics Inc., Cue Health Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Laboratory Corp. of America Holdings, Mammoth Biosciences Inc., MyBioSource Inc., QIAGEN NV, Quidelortho Corp., RayBiotech Life Inc., Robert Bosch GmbH, SHERLOCK BIOSCIENCES, Talis Biomedical Corp., and Thermo Fisher Scientific Inc.. Also, the test kits market in North America analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary €“ Chart on Market Overview
Exhibit 02: Executive Summary €“ Data Table on Market Overview
Exhibit 03: Executive Summary €“ Chart on Country Market Characteristics
Exhibit 04: Executive Summary €“ Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary €“ Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary €“ Chart on Market Segmentation by Type
Exhibit 07: Executive Summary €“ Chart on Incremental Growth
Exhibit 08: Executive Summary €“ Data Table on Incremental Growth
Exhibit 09: Executive Summary €“ Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on North America: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 18: Five forces analysis - Comparison between 2022 and 2027
4.2 Bargaining power of buyers
Exhibit 19: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
4.3 Bargaining power of suppliers
Exhibit 20: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
4.4 Threat of new entrants
Exhibit 21: Threat of new entrants €“ Impact of key factors in 2022 and 2027
4.5 Threat of substitutes
Exhibit 22: Threat of substitutes €“ Impact of key factors in 2022 and 2027
4.6 Threat of rivalry
Exhibit 23: Threat of rivalry €“ Impact of key factors in 2022 and 2027
4.7 Market condition
Exhibit 24: Chart on Market condition - Five forces 2022 and 2027
5 Market Segmentation by End-user
5.1 Market segments
Exhibit 25: Chart on End-user - Market share 2022-2027 (%)
Exhibit 26: Data Table on End-user - Market share 2022-2027 (%)
5.2 Comparison by End-user
Exhibit 27: Chart on Comparison by End-user
Exhibit 28: Data Table on Comparison by End-user
5.3 Government - Market size and forecast 2022-2027
Exhibit 29: Chart on Government - Market size and forecast 2022-2027 ($ billion)
Exhibit 30: Data Table on Government - Market size and forecast 2022-2027 ($ billion)
Exhibit 31: Chart on Government - Year-over-year growth 2022-2027 (%)
Exhibit 32: Data Table on Government - Year-over-year growth 2022-2027 (%)
5.4 Non-government - Market size and forecast 2022-2027
Exhibit 33: Chart on Non-government - Market size and forecast 2022-2027 ($ billion)
Exhibit 34: Data Table on Non-government - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Chart on Non-government - Year-over-year growth 2022-2027 (%)
Exhibit 36: Data Table on Non-government - Year-over-year growth 2022-2027 (%)
5.5 Market opportunity by End-user
Exhibit 37: Market opportunity by End-user ($ billion)
Exhibit 38: Data Table on Market opportunity by End-user ($ billion)
6 Market Segmentation by Type
6.1 Market segments
Exhibit 39: Chart on Type - Market share 2022-2027 (%)
Exhibit 40: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 41: Chart on Comparison by Type
Exhibit 42: Data Table on Comparison by Type
6.3 Rapid test kit - Market size and forecast 2022-2027
Exhibit 43: Chart on Rapid test kit - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Data Table on Rapid test kit - Market size and forecast 2022-2027 ($ billion)
Exhibit 45: Chart on Rapid test kit - Year-over-year growth 2022-2027 (%)
Exhibit 46: Data Table on Rapid test kit - Year-over-year growth 2022-2027 (%)
6.4 RT-PCR - Market size and forecast 2022-2027
Exhibit 47: Chart on RT-PCR - Market size and forecast 2022-2027 ($ billion)
Exhibit 48: Data Table on RT-PCR - Market size and forecast 2022-2027 ($ billion)
Exhibit 49: Chart on RT-PCR - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on RT-PCR - Year-over-year growth 2022-2027 (%)
6.5 Others - Market size and forecast 2022-2027
Exhibit 51: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 52: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 53: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Type
Exhibit 55: Market opportunity by Type ($ billion)
Exhibit 56: Data Table on Market opportunity by Type ($ billion)
7 Customer Landscape
7.1 Customer landscape overview
Exhibit 57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
Exhibit 58: Chart on Market share By Geographical Landscape - 2022-2027 (%)
Exhibit 59: Data Table on Market share By Geographical Landscape - 2022-2027 (%)
8.2 Geographic comparison
Exhibit 60: Chart on Geographic comparison
Exhibit 61: Data Table on Geographic comparison
8.3 US - Market size and forecast 2022-2027
Exhibit 62: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 63: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 64: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2022-2027 (%)
8.4 Canada - Market size and forecast 2022-2027
Exhibit 66: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 67: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 68: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 69: Data Table on Canada - Year-over-year growth 2022-2027 (%)
8.5 Mexico - Market size and forecast 2022-2027
Exhibit 70: Chart on Mexico - Market size and forecast 2022-2027 ($ billion)
Exhibit 71: Data Table on Mexico - Market size and forecast 2022-2027 ($ billion)
Exhibit 72: Chart on Mexico - Year-over-year growth 2022-2027 (%)
Exhibit 73: Data Table on Mexico - Year-over-year growth 2022-2027 (%)
8.6 Market opportunity By Geographical Landscape
Exhibit 74: Market opportunity By Geographical Landscape ($ billion)
Exhibit 75: Data Table on Market opportunity By Geographical Landscape ($ billion)
9 Drivers, Challenges, and Trends
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Exhibit 76: Impact of drivers and challenges in 2022 and 2027
9.4 Market trends
10 Vendor Landscape
10.1 Overview
10.2 Vendor landscape
Exhibit 77: Overview on Criticality of inputs and Factors of differentiation
10.3 Landscape disruption
Exhibit 78: Overview on factors of disruption
10.4 Industry risks
Exhibit 79: Impact of key risks on business
11 Vendor Analysis
11.1 Vendors covered
Exhibit 80: Vendors covered
11.2 Market positioning of vendors
Exhibit 81: Matrix on vendor position and classification
11.3 Abbott Laboratories
Exhibit 82: Abbott Laboratories - Overview
Exhibit 83: Abbott Laboratories - Business segments
Exhibit 84: Abbott Laboratories - Key news
Exhibit 85: Abbott Laboratories - Key offerings
Exhibit 86: Abbott Laboratories - Segment focus
11.4 Advaite Inc.
Exhibit 87: Advaite Inc. - Overview
Exhibit 88: Advaite Inc. - Product/Service
Exhibit 89: Advaite Inc. - Key offerings
11.5 Becton Dickinson and Co.
Exhibit 90: Becton Dickinson and Co. - Overview
Exhibit 91: Becton Dickinson and Co. - Business segments
Exhibit 92: Becton Dickinson and Co. - Key news
Exhibit 93: Becton Dickinson and Co. - Key offerings
Exhibit 94: Becton Dickinson and Co. - Segment focus
11.6 Biomedomics Inc.
Exhibit 95: Biomedomics Inc. - Overview
Exhibit 96: Biomedomics Inc. - Product/Service
Exhibit 97: Biomedomics Inc. - Key offerings
11.7 bioMerieux SA
Exhibit 98: bioMerieux SA - Overview
Exhibit 99: bioMerieux SA - Product/Service
Exhibit 100: bioMerieux SA - Key news
Exhibit 101: bioMerieux SA - Key offerings
11.8 Cellex Inc.
Exhibit 102: Cellex Inc. - Overview
Exhibit 103: Cellex Inc. - Product/Service
Exhibit 104: Cellex Inc. - Key offerings
11.9 Co Diagnostics Inc.
Exhibit 105: Co Diagnostics Inc. - Overview
Exhibit 106: Co Diagnostics Inc. - Product/Service
Exhibit 107: Co Diagnostics Inc. - Key news
Exhibit 108: Co Diagnostics Inc. - Key offerings
11.10 Cue Health Inc.
Exhibit 109: Cue Health Inc. - Overview
Exhibit 110: Cue Health Inc. - Product/Service
Exhibit 111: Cue Health Inc. - Key offerings
11.11 Danaher Corp.
Exhibit 112: Danaher Corp. - Overview
Exhibit 113: Danaher Corp. - Business segments
Exhibit 114: Danaher Corp. - Key news
Exhibit 115: Danaher Corp. - Key offerings
Exhibit 116: Danaher Corp. - Segment focus
11.12 DiaSorin SpA
Exhibit 117: DiaSorin SpA - Overview
Exhibit 118: DiaSorin SpA - Business segments
Exhibit 119: DiaSorin SpA - Key news
Exhibit 120: DiaSorin SpA - Key offerings
Exhibit 121: DiaSorin SpA - Segment focus
11.13 F. Hoffmann La Roche Ltd.
Exhibit 122: F. Hoffmann La Roche Ltd. - Overview
Exhibit 123: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 124: F. Hoffmann La Roche Ltd. - Key news
Exhibit 125: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 126: F. Hoffmann La Roche Ltd. - Segment focus
11.14 Hologic Inc.
Exhibit 127: Hologic Inc. - Overview
Exhibit 128: Hologic Inc. - Business segments
Exhibit 129: Hologic Inc. - Key news
Exhibit 130: Hologic Inc. - Key offerings
Exhibit 131: Hologic Inc. - Segment focus
11.15 Laboratory Corp. of America Holdings
Exhibit 132: Laboratory Corp. of America Holdings - Overview
Exhibit 133: Laboratory Corp. of America Holdings - Business segments
Exhibit 134: Laboratory Corp. of America Holdings - Key news
Exhibit 135: Laboratory Corp. of America Holdings - Key offerings
Exhibit 136: Laboratory Corp. of America Holdings - Segment focus
11.16 QIAGEN NV
Exhibit 137: QIAGEN NV - Overview
Exhibit 138: QIAGEN NV - Product/Service
Exhibit 139: QIAGEN NV - Key news
Exhibit 140: QIAGEN NV - Key offerings
11.17 Thermo Fisher Scientific Inc.
Exhibit 141: Thermo Fisher Scientific Inc. - Overview
Exhibit 142: Thermo Fisher Scientific Inc. - Business segments
Exhibit 143: Thermo Fisher Scientific Inc. - Key news
Exhibit 144: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 145: Thermo Fisher Scientific Inc. - Segment focus
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Exhibit 146: Inclusions checklist
Exhibit 147: Exclusions checklist
12.3 Currency conversion rates for US$
Exhibit 148: Currency conversion rates for US$
12.4 Research methodology
Exhibit 149: Research methodology
Exhibit 150: Validation techniques employed for market sizing
Exhibit 151: Information sources
12.5 List of abbreviations
Exhibit 152: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary €“ Chart on Market Overview
Exhibits 2: Executive Summary €“ Data Table on Market Overview
Exhibits 3: Executive Summary €“ Chart on Country Market Characteristics
Exhibits 4: Executive Summary €“ Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary €“ Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary €“ Chart on Market Segmentation by Type
Exhibits 7: Executive Summary €“ Chart on Incremental Growth
Exhibits 8: Executive Summary €“ Data Table on Incremental Growth
Exhibits 9: Executive Summary €“ Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits 15: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)
Exhibits 16: Chart on North America: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)
Exhibits 18: Five forces analysis - Comparison between 2022 and 2027
Exhibits 19: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
Exhibits 20: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
Exhibits 21: Threat of new entrants €“ Impact of key factors in 2022 and 2027
Exhibits 22: Threat of substitutes €“ Impact of key factors in 2022 and 2027
Exhibits 23: Threat of rivalry €“ Impact of key factors in 2022 and 2027
Exhibits 24: Chart on Market condition - Five forces 2022 and 2027
Exhibits 25: Chart on End-user - Market share 2022-2027 (%)
Exhibits 26: Data Table on End-user - Market share 2022-2027 (%)
Exhibits 27: Chart on Comparison by End-user
Exhibits 28: Data Table on Comparison by End-user
Exhibits 29: Chart on Government - Market size and forecast 2022-2027 ($ billion)
Exhibits 30: Data Table on Government - Market size and forecast 2022-2027 ($ billion)
Exhibits 31: Chart on Government - Year-over-year growth 2022-2027 (%)
Exhibits 32: Data Table on Government - Year-over-year growth 2022-2027 (%)
Exhibits 33: Chart on Non-government - Market size and forecast 2022-2027 ($ billion)
Exhibits 34: Data Table on Non-government - Market size and forecast 2022-2027 ($ billion)
Exhibits 35: Chart on Non-government - Year-over-year growth 2022-2027 (%)
Exhibits 36: Data Table on Non-government - Year-over-year growth 2022-2027 (%)
Exhibits 37: Market opportunity by End-user ($ billion)
Exhibits 38: Data Table on Market opportunity by End-user ($ billion)
Exhibits 39: Chart on Type - Market share 2022-2027 (%)
Exhibits 40: Data Table on Type - Market share 2022-2027 (%)
Exhibits 41: Chart on Comparison by Type
Exhibits 42: Data Table on Comparison by Type
Exhibits 43: Chart on Rapid test kit - Market size and forecast 2022-2027 ($ billion)
Exhibits 44: Data Table on Rapid test kit - Market size and forecast 2022-2027 ($ billion)
Exhibits 45: Chart on Rapid test kit - Year-over-year growth 2022-2027 (%)
Exhibits 46: Data Table on Rapid test kit - Year-over-year growth 2022-2027 (%)
Exhibits 47: Chart on RT-PCR - Market size and forecast 2022-2027 ($ billion)
Exhibits 48: Data Table on RT-PCR - Market size and forecast 2022-2027 ($ billion)
Exhibits 49: Chart on RT-PCR - Year-over-year growth 2022-2027 (%)
Exhibits 50: Data Table on RT-PCR - Year-over-year growth 2022-2027 (%)
Exhibits 51: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits 52: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits 53: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 54: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 55: Market opportunity by Type ($ billion)
Exhibits 56: Data Table on Market opportunity by Type ($ billion)
Exhibits 57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 58: Chart on Market share By Geographical Landscape - 2022-2027 (%)
Exhibits 59: Data Table on Market share By Geographical Landscape - 2022-2027 (%)
Exhibits 60: Chart on Geographic comparison
Exhibits 61: Data Table on Geographic comparison
Exhibits 62: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 63: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 64: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 65: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 66: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits 67: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits 68: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 69: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 70: Chart on Mexico - Market size and forecast 2022-2027 ($ billion)
Exhibits 71: Data Table on Mexico - Market size and forecast 2022-2027 ($ billion)
Exhibits 72: Chart on Mexico - Year-over-year growth 2022-2027 (%)
Exhibits 73: Data Table on Mexico - Year-over-year growth 2022-2027 (%)
Exhibits 74: Market opportunity By Geographical Landscape ($ billion)
Exhibits 75: Data Table on Market opportunity By Geographical Landscape ($ billion)
Exhibits 76: Impact of drivers and challenges in 2022 and 2027
Exhibits 77: Overview on Criticality of inputs and Factors of differentiation
Exhibits 78: Overview on factors of disruption
Exhibits 79: Impact of key risks on business
Exhibits 80: Vendors covered
Exhibits 81: Matrix on vendor position and classification
Exhibits 82: Abbott Laboratories - Overview
Exhibits 83: Abbott Laboratories - Business segments
Exhibits 84: Abbott Laboratories - Key news
Exhibits 85: Abbott Laboratories - Key offerings
Exhibits 86: Abbott Laboratories - Segment focus
Exhibits 87: Advaite Inc. - Overview
Exhibits 88: Advaite Inc. - Product/Service
Exhibits 89: Advaite Inc. - Key offerings
Exhibits 90: Becton Dickinson and Co. - Overview
Exhibits 91: Becton Dickinson and Co. - Business segments
Exhibits 92: Becton Dickinson and Co. - Key news
Exhibits 93: Becton Dickinson and Co. - Key offerings
Exhibits 94: Becton Dickinson and Co. - Segment focus
Exhibits 95: Biomedomics Inc. - Overview
Exhibits 96: Biomedomics Inc. - Product/Service
Exhibits 97: Biomedomics Inc. - Key offerings
Exhibits 98: bioMerieux SA - Overview
Exhibits 99: bioMerieux SA - Product/Service
Exhibits 100: bioMerieux SA - Key news
Exhibits 101: bioMerieux SA - Key offerings
Exhibits 102: Cellex Inc. - Overview
Exhibits 103: Cellex Inc. - Product/Service
Exhibits 104: Cellex Inc. - Key offerings
Exhibits 105: Co Diagnostics Inc. - Overview
Exhibits 106: Co Diagnostics Inc. - Product/Service
Exhibits 107: Co Diagnostics Inc. - Key news
Exhibits 108: Co Diagnostics Inc. - Key offerings
Exhibits 109: Cue Health Inc. - Overview
Exhibits 110: Cue Health Inc. - Product/Service
Exhibits 111: Cue Health Inc. - Key offerings
Exhibits 112: Danaher Corp. - Overview
Exhibits 113: Danaher Corp. - Business segments
Exhibits 114: Danaher Corp. - Key news
Exhibits 115: Danaher Corp. - Key offerings
Exhibits 116: Danaher Corp. - Segment focus
Exhibits 117: DiaSorin SpA - Overview
Exhibits 118: DiaSorin SpA - Business segments
Exhibits 119: DiaSorin SpA - Key news
Exhibits 120: DiaSorin SpA - Key offerings
Exhibits 121: DiaSorin SpA - Segment focus
Exhibits 122: F. Hoffmann La Roche Ltd. - Overview
Exhibits 123: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 124: F. Hoffmann La Roche Ltd. - Key news
Exhibits 125: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 126: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 127: Hologic Inc. - Overview
Exhibits 128: Hologic Inc. - Business segments
Exhibits 129: Hologic Inc. - Key news
Exhibits 130: Hologic Inc. - Key offerings
Exhibits 131: Hologic Inc. - Segment focus
Exhibits 132: Laboratory Corp. of America Holdings - Overview
Exhibits 133: Laboratory Corp. of America Holdings - Business segments
Exhibits 134: Laboratory Corp. of America Holdings - Key news
Exhibits 135: Laboratory Corp. of America Holdings - Key offerings
Exhibits 136: Laboratory Corp. of America Holdings - Segment focus
Exhibits 137: QIAGEN NV - Overview
Exhibits 138: QIAGEN NV - Product/Service
Exhibits 139: QIAGEN NV - Key news
Exhibits 140: QIAGEN NV - Key offerings
Exhibits 141: Thermo Fisher Scientific Inc. - Overview
Exhibits 142: Thermo Fisher Scientific Inc. - Business segments
Exhibits 143: Thermo Fisher Scientific Inc. - Key news
Exhibits 144: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 145: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 146: Inclusions checklist
Exhibits 147: Exclusions checklist
Exhibits 148: Currency conversion rates for US$
Exhibits 149: Research methodology
Exhibits 150: Validation techniques employed for market sizing
Exhibits 151: Information sources
Exhibits 152: List of abbreviations

Executive Summary

The research team recognises the following companies as the key players in the test kits market in North America: Abbott Laboratories, Advaite Inc., Becton Dickinson and Co., Biomedomics Inc., bioMerieux SA, Cellex Inc., Co Diagnostics Inc., Cue Health Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Laboratory Corp. of America Holdings, Mammoth Biosciences Inc., MyBioSource Inc., QIAGEN NV, Quidelortho Corp., RayBiotech Life Inc., Robert Bosch GmbH, SHERLOCK BIOSCIENCES, Talis Biomedical Corp., and Thermo Fisher Scientific Inc..

One of the report's analysts commented on the report, saying: 'The latest trend gaining momentum in the market is launch of new COVID-19 test kits.'

According to the report, one of the major drivers for this market is the rising adoption of rapid coronavirus test kits.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Advaite Inc.
  • Becton Dickinson and Co.
  • Biomedomics Inc.
  • bioMerieux SA
  • Cellex Inc.
  • Co Diagnostics Inc.
  • Cue Health Inc.
  • Danaher Corp.
  • DiaSorin SpA
  • F. Hoffmann La Roche Ltd.
  • Hologic Inc.
  • Laboratory Corp. of America Holdings
  • Mammoth Biosciences Inc.
  • MyBioSource Inc.
  • QIAGEN NV
  • Quidelortho Corp.
  • RayBiotech Life Inc.
  • Robert Bosch GmbH
  • SHERLOCK BIOSCIENCES
  • Talis Biomedical Corp.
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Global Coronavirus Test Kits Market 2023-2027 - Product Image

Global Coronavirus Test Kits Market 2023-2027

  • Report
  • 155 Pages
  • Global
From
COVID-19 Detection Kits Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028) - Product Image

COVID-19 Detection Kits Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

  • Report
  • 120 Pages
  • Global
From
Global Coronavirus Test Kits Market by Product Type (Immunoassay Test Strips or Cassettes, RT-PCR Assay Kits, Self-testing Kits), Specimen Type (Nasal Swab, Nasopharyngeal Swab, Oropharyngeal Swab), End-User - Forecast 2024-2030 - Product Image

Global Coronavirus Test Kits Market by Product Type (Immunoassay Test Strips or Cassettes, RT-PCR Assay Kits, Self-testing Kits), Specimen Type (Nasal Swab, Nasopharyngeal Swab, Oropharyngeal Swab), End-User - Forecast 2024-2030

  • Report
  • 186 Pages
  • Global
From
Global Influenza Diagnostics Market 2023-2027 - Product Image

Global Influenza Diagnostics Market 2023-2027

  • Report
  • 170 Pages
  • Global
From
COVID-19 Testing Markets, 2023 - Product Image

COVID-19 Testing Markets, 2023

  • Report
  • 131 Pages
  • Global
From

About the POC COVID Diagnostics Market

The POC COVID Diagnostics market is a subset of the Diagnostics industry, focused on the development and production of point-of-care (POC) tests for the detection of the novel coronavirus. These tests are designed to provide rapid results, allowing for quick diagnosis and treatment of patients. POC COVID Diagnostics tests are typically conducted using a variety of methods, such as antigen tests, antibody tests, and molecular tests. The POC COVID Diagnostics market has seen a surge in demand due to the pandemic, with many companies investing in the development of new tests and technologies. This has led to an increase in the number of companies offering POC COVID Diagnostics tests, as well as an increase in the number of tests available. Some of the companies in the POC COVID Diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Roche Diagnostics, and Quidel Corporation. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.